FMR LLC 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | Apogee Therapeutics, Inc. APGE | FMR LLC | 7,502,482 16.672% | 2,483,602 (+49.49%) | Filing |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Apogee Therapeutics, Inc. APGE | FMR LLC | 5,018,880 13.496% | 570,979 (+12.84%) | Filing |
| 2023-08-10 08:19 am Purchase | 2023-08-09 | 13G | Apogee Therapeutics, Inc. APGE | FMR LLC | 4,447,901 12.094% | 4,447,901 (New Position) | Filing |